skip to main content

Fall, 2012

Paula Wishart is a cancer dodger. Thanks to the University of Michigan Cancer Genetics Clinic, she was diagnosed with Lynch Syndrome, a hereditary condition that greatly increases the chances of developing colon and other cancers earlier in life than what’s considered typical.

Sherron Tornow says she's a lucky woman. After her physician diagnosed the lump on her neck as lymphoma, family, friends and neighbors rallied to offer support. She also shared her cancer experience with an unexpected new friend who was key to her support system: a fellow patient she met while preparing for a stem cell transplant.

Wounds are a common side effect of cancer and cancer treatments. Chemotherapy or oral drugs can cause skin toxicities like rashes and dry skin that can be uncomfortable and bothersome to patients. Certain cancers develop tumors underneath the skin that can break down, leak and cause unpleasant odor and infection.

With the goal of meeting the needs of cancer patients, the University of Michigan Rogel Cancer Center created an Ambulatory Treatment Center. The improved service provides ongoing support for U-M Cancer Center patients as well as regular clinic visits for physician appointments and treatment.

What goes into researching and developing a cancer drug and what is required for FDA approval? We sat down with Moshe Talpaz, M.D., associate director of translational research at the U-M Rogel Cancer Center, for a closer look at the FDA approval process.

If you're currently undergoing cancer treatment and losing weight, now is the time to indulge in comfort foods. Macaroni and cheese, chicken noodle soup, meatloaf, mashed potatoes and ice cream can be great options as their high calories, creamy textures and low-fiber content make them easy to chew and digest.

Cancer medications taken by mouth may be more convenient and, in some cases, require less frequent doctor visits than intravenous treatments (infusion). As more is known about how cancers develop and spread, a growing number of oral medications that target particular pathways or receptors have been developed.